The antipsychotic lumateperone (Caplyta) and the hypnotic lemborexant (Dayvigo) are the newest in their class. Both of them claim to improve on the safety of older medications, and we look at the data to see how those claims hold up.
You want to help every family that calls, but your schedule's full, and the need keeps growing. What can you do when you can't take another patient? In this episode, we will...